Dynamic alteration of gene expression induced by anticancer-agent exposure in gastric cancer cell lines

被引:7
作者
Takahashi, Tsunehiro
Saikawa, Yoshiro [1 ]
Nakamura, Rieko
Kumagai, Koshi
Takeuchi, Hiroya
Kubota, Tetsuro [2 ]
Kitagawa, Yuko
机构
[1] Keio Univ, Dept Surg, Sch Med, Shinjuku Ku, Tokyo 1608582, Japan
[2] Keio Univ Hosp, Ctr Comprehens & Adv Med, Shinjuku Ku, Tokyo 1608582, Japan
关键词
gastric cancer cell line; cisplatin; 5-fluorouracil; low density array; messenger RNA quantification; THYMIDYLATE SYNTHASE; CARCINOMA CELLS; MTT ASSAY; CHEMOTHERAPY; RESISTANCE; CISPLATIN; MECHANISMS; FLUOROPYRIMIDINE; PROGRESSION; ACTIVATION;
D O I
10.3892/or_00000244
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The prognosis for advanced gastric cancer remains very poor due to the limited effectiveness of chemotherapy agents. The range in efficacy of these chemotherapy agents is likely the result of various factors including gene expression. In addition, the emergence of drug resistance during chemotherapy can result in the undesirable outcome of patients experiencing the side effects of chemotherapy without benefiting in terms of tumor response. Gene expression profiling provides a unique opportunity to gain insight into the development of different types of gastric cancer. We applied the TaqMan low density array to investigate the expression of 96 genes in four gastric cancer cell lines (TMK-1, MKN-45, MKN-74 and CDDP-resistant MKN-74). The cell lines displayed different patterns of gene expression alteration after exposure to the chemotherapeutic drugs cisplatin and 5-fluorouracil. We also established that cisplatin-resistant MKN-74 cells do not show the same gene expression patterns as the parental MKN-74 cell line at 0, 8 and 24 It after CDDP exposure. This study reveals the underlying complexity of biological and pathological events and could, perhaps, contribute to new experimental protocols or treatments that would achieve a consistent and desirable outcome of chemotherapy.
引用
收藏
页码:451 / 459
页数:9
相关论文
共 34 条
[1]  
Andrews P A, 1994, Cancer Treat Res, V73, P217
[2]   Thymidylate Synthase expression as a predictor of clinical response to fluoropyrimidine-based chemotherapy in advanced colorectal cancer [J].
Aschele, C ;
Lonardi, S ;
Monfardini, S .
CANCER TREATMENT REVIEWS, 2002, 28 (01) :27-47
[3]   Novel aspects of resistance to drugs targeted to dihydrofolate reductase and thymidylate synthase [J].
Banerjee, D ;
Mayer-Kuckuk, P ;
Capiaux, G ;
Budak-Alpdogan, T ;
Gorlick, R ;
Bertino, JR .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2002, 1587 (2-3) :164-173
[4]   Molecular classification of cancer: Class discovery and class prediction by gene expression monitoring [J].
Golub, TR ;
Slonim, DK ;
Tamayo, P ;
Huard, C ;
Gaasenbeek, M ;
Mesirov, JP ;
Coller, H ;
Loh, ML ;
Downing, JR ;
Caligiuri, MA ;
Bloomfield, CD ;
Lander, ES .
SCIENCE, 1999, 286 (5439) :531-537
[5]  
Gosland M, 1996, PHARMACOTHERAPY, V16, P16
[6]   Mechanisms of cancer drug resistance [J].
Gottesman, MM .
ANNUAL REVIEW OF MEDICINE, 2002, 53 :615-627
[7]   Characterization of a side population of cancer cells from human gastrointestinal system [J].
Haraguchi, Naotsugu ;
Utsunomiya, Tohru ;
Inoue, Hiroshi ;
Tanaka, Fumiaki ;
Mimori, Koshi ;
Barnard, Graham F. ;
Mori, Masaki .
STEM CELLS, 2006, 24 (03) :506-513
[8]   Intravenous chemotherapy for resected gastric cancer: meta-analysis of randomized controlled trials [J].
Hu, JK ;
Chen, ZX ;
Zhou, ZG ;
Zhang, B ;
Tian, J ;
Chen, JP ;
Wang, L ;
Wang, CH ;
Chen, HY ;
Li, YP .
WORLD JOURNAL OF GASTROENTEROLOGY, 2002, 8 (06) :1023-1028
[9]   Biological and genetic characteristics of tumor-initiating cells in colon cancer [J].
Ieta, Keisuke ;
Tanaka, Fumiaki ;
Haraguchi, Naotsugu ;
Kita, Yoshiaki ;
Sakashita, Hiroyuki ;
Mimori, Koshi ;
Matsumoto, Toshifumi ;
Inoue, Hiroshi ;
Kuwano, Hiroyuki ;
Mori, Masaki .
ANNALS OF SURGICAL ONCOLOGY, 2008, 15 (02) :638-648
[10]   Predicting 5-FU sensitivity using human colorectal cancer specimens: Comparison of tumor dihydropyrimidine dehydrogenase and orotate phosphoribosyl transferase activities with in vitro chemosensitivity to 5-FU [J].
Isshi K. ;
Sakuyama T. ;
Gen T. ;
Nakamura Y. ;
Kuroda T. ;
Katuyama T. ;
Maekawa Y. .
International Journal of Clinical Oncology, 2002, 7 (6) :335-342